ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2025-11565

CWE-22: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability exists that could cause elevated system access when a Web Admin us…

Published Nov 12, 2025 · catalog updated Oct 18, 2026 · the affected product

Open the advisory

Exploitation likelihood is not on this record for CVE-2025-11565. A missing EPSS score is not a low risk. Compare the affected product with the linked advisory before you change production.

Gaps on this record

  • No plain product name is stored. The page cannot tell you which product to check.
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
  • EPSS is missing. A missing score is not a low risk.
Severity
High7.3
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
Awaiting synchronization with FIRST
Remediation
Advisory link
Affected products
See sources for product scope

CWE-22: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability exists that could cause elevated system access when a Web Admin user on the local network tampers with the POST /REST/UpdateJRE request payload.

No affected version ranges are stored yet. Use the vendor advisory before you decide this record does not apply.

How to fix CVE-2025-11565

  • Recommended remediation

    A patch or advisory reference is linked. Open the original publisher for availability by product version.

  • Official advisories

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

Exploitation likelihood is not on this record for CVE-2025-11565. A missing EPSS score is not a low risk. Compare the affected product with the linked advisory before you change production.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-22: Path Traversal. EPSS is not on this record yet. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Nov 12, 2025 · NIST NVD

    Detected

    CWE-22: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability exists that could cause elevated system access when a Web Admin user on the local network tampers with the POST /REST/UpdateJRE request payload.

  2. Oct 18, 2026 · NIST NVD

    Updated

    CWE-22: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability exists that could cause elevated system access when a Web Admin user on the local network tampers with the POST /REST/UpdateJRE request payload.

Sources

  • NIST NVDVulnerability recordCVE-2025-11565

    CWE-22: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability exists that could cause elevated system access when a Web Admin user on the local network tampers with the POST /REST/UpdateJRE request payload.

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.